Embryonic stem cells,
Tissue-specific stem cells.
Let's do this by process of elimination: A cannot be the answer because glucose is broken down, not built up or synthesized. B is ruled out for the same reason. D is incorrect because transpiration results in water loss, not energy gain. The only correct answer choice is C respiration, specifically by the process of substrate-level phosphorylation during glycolysis in order to break down glucose into two pyruvate molecules and two net ATP
I recommend reading a passage about it. Hope this helps!
Answer:
The new drug will not be effective against the treatment of cancer.
Explanation:
The drug will not be effective against the cancer treatment because the drug will inhibit the dimerization of receptor tyrosine kinase (RTK) but as the Ras has undergone mutation due to replacement of one amino acid, it will be constitutively expressed and the drug is not effective in stopping the Ras functioning.
Thus, Gefitinib cannot work against the cancerous cell as it is not potent to stop the functioning of mutant Ras protein.